Recombinant T-cell Receptor Ligands: Immunomodulatory, Neuroprotective and Neuroregenerative Effects Suggest Application as Therapy for Multiple Sclerosis

Eitemau Tebyg

• Cytokine Switch and Bystander Suppression of Autoimmune Responses to Multiple Antigens in Experimental Autoimmune Encephalomyelitis by a Single Recombinant T-Cell Receptor Ligand
  gan: Sinha, Sushmita, et al.
  Cyhoeddwyd: (2009)
• A Promising Therapeutic Approach for Multiple Sclerosis: Recombinant T-Cell Receptor Ligands Modulate Experimental Autoimmune Encephalomyelitis by Reducing Interleukin-17 Production and Inhibiting Migration of Encephalitogenic Cells into the CNS
  gan: Sinha, Sushmita, et al.
  Cyhoeddwyd: (2007)
• RTL THERAPY FOR MULTIPLE SCLEROSIS: A Phase I Clinical Study
  gan: Offner, Halina, et al.
  Cyhoeddwyd: (2010)
• Recombinant TCR ligand reverses clinical signs and CNS damage of EAE induced by recombinant human MOG
  gan: Sinha, Sushmita, et al.
  Cyhoeddwyd: (2009)
• Characterization of human platelet binding of recombinant T cell receptor ligand
  gan: Itakura, Asako, et al.
  Cyhoeddwyd: (2010)